Healthcare -
Medical - Devices - NASDAQ - US
$ 24.07
-2.71 %
$ 585 M
Market Cap
-14.68
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
OrthoPediatrics Corp.
| Revenue | 205 M |
| Cost Of Revenue | 56.1 M |
| Gross Profit | 149 M |
| Operating Expenses | 178 M |
| Operating Income | -29.5 M |
| Other Expenses | 8.3 M |
| Net Income | -37.8 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Revenue | 204.7 | 148.7 | 122.3 | 98.0 | 71.1 | 72.6 | 57.6 | 45.6 | 37.3 | 31.0 | 23.7 |
| GROSS PROFIT | |||||||||||
| Cost Of Revenue | 56.1 | 37.5 | 31.6 | 24.6 | 16.0 | 17.9 | 14.9 | 11.2 | 10.9 | 9.4 | 7.1 |
| Gross Profit | 148.6 | 111.3 | 90.7 | 73.4 | 55.0 | 54.6 | 42.7 | 34.5 | 26.4 | 21.6 | 16.6 |
| OPERATING INCOME | |||||||||||
| Operating Expenses | 178.1 | 137.0 | 112.5 | 91.3 | 75.4 | 63.7 | 52.2 | 40.9 | 32.5 | 28.2 | 23.7 |
| Selling, General and Administrative Expenses | 167.1 | 126.8 | 104.4 | 85.7 | 70.2 | 57.9 | 47.5 | 37.5 | 30.3 | 26.4 | 22.1 |
| Research and Development Expenses | 11.0 | 10.2 | 8.0 | 5.5 | 5.3 | 5.7 | 4.7 | 3.4 | 2.2 | 1.8 | 1.7 |
| Operating Income | (29.5) | (25.8) | (21.8) | (17.9) | (20.4) | (9.1) | (9.6) | (6.5) | (6.1) | (6.6) | (7.1) |
| PRE-TAX INCOME | |||||||||||
| Interest Income Expense | 2.6 | 0 | 2.4 | 2.2 | 3.4 | 3.5 | 2.3 | 2.5 | 1.5 | 1.2 | 2.5 |
| Total Other Income | (12.4) | 4.5 | 18.1 | 0.5 | (6.9) | (3.6) | (2.5) | (2.5) | (0.4) | (1.3) | (2.6) |
| Pre-Tax Income | (41.9) | (21.3) | (3.7) | (17.4) | (33.7) | (12.7) | (12.0) | (8.9) | (6.6) | (7.9) | (9.8) |
| NET INCOME | |||||||||||
| Tax Provision | (4.1) | (0.3) | (4.9) | (1.1) | (0.7) | 4.5 | (0.2) | 2.5 | 2.5 | 1.2 | 2.3 |
| Net Income | (37.8) | (21.0) | 1.3 | (16.3) | (32.9) | (17.2) | (12.0) | (8.9) | (6.6) | (7.9) | (9.5) |
| EPS | 1.64 | 0.92 | 0.0596 | 0.84 | 1.82 | 1.18 | 0.96 | 1.85 | 0.87 | 1.05 | 1.28 |